Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring

10 Dec 2004

Abstract excerpt

BACKGROUND: Determination of antigen expression patterns is, in addition to morphologic analysis, essential to the diagnosis of acute myeloid leukemia (AML). The present study was performed to determine (a) the degree of changes in immunophenotype and their consequences on the monitoring of minimal residual disease (MRD) in childhood AML and (b) whether certain clusters of changes in antigen expression patterns...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Acute Myeloid Leukemia Research
Share to Hematopoietic Stem Cell Transplantation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15624201
DOI: 10.1002/cyto.b.20037

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoringPMID 15624201Read ↗

Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group.Semantic proximity Read ↗

Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.Semantic proximity Read ↗

Characterization of aberrant phenotypes in acute myeloblastic leukemia.Semantic proximity Read ↗

Immunophenotypic modulation in pediatric B lymphoblastic leukemia and its implications in MRD detectionSemantic proximity Read ↗

Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis: implications for minimal residual disease studies.Semantic proximity Read ↗

Phenotypic changes in acute myeloid leukaemia: implications in the detection of minimal residual disease.Semantic proximity Read ↗

Stability of leukemia‐associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: Comparison with cytomorphologic, cytogenetic, and molecular genetic findingsSemantic proximity Read ↗

Antigen Expression Varies Significantly between Molecular Subgroups of Acute Myeloid Leukemia Patients: Clinical Applicability Is Hampered by Establishment of Relevant Cutoffs.Semantic proximity Read ↗

A subset of acute lymphoblastic leukemia with co-expression of myeloid antigens: prevalence and clinical significance.Semantic proximity Read ↗

Modulation of antigen expression in B‐cell precursor acute lymphoblastic leukemia during induction therapy is partly transient: Evidence for a drug‐induced regulatory phenomenon. Results of the AIEOP‐BFM‐ALL‐FLOW‐MRD‐Study GroupSemantic proximity Read ↗

[Phenotypic changes in refractory and relapse acute lymphoblastic leukemias].Semantic proximity Read ↗

Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.